Poole, R.A.; Wang, Q.; Ray, A.; Takabe, K.; Opyrchal, M.; Katsuta, E.
Increased PIEZO1 Expression Is Associated with Worse Clinical Outcomes in Hormone-Receptor-Negative Breast Cancer Patients. Cancers 2024, 16, 683.
https://doi.org/10.3390/cancers16040683
AMA Style
Poole RA, Wang Q, Ray A, Takabe K, Opyrchal M, Katsuta E.
Increased PIEZO1 Expression Is Associated with Worse Clinical Outcomes in Hormone-Receptor-Negative Breast Cancer Patients. Cancers. 2024; 16(4):683.
https://doi.org/10.3390/cancers16040683
Chicago/Turabian Style
Poole, Rylee Ann, Qingfei Wang, Alo Ray, Kazuaki Takabe, Mateusz Opyrchal, and Eriko Katsuta.
2024. "Increased PIEZO1 Expression Is Associated with Worse Clinical Outcomes in Hormone-Receptor-Negative Breast Cancer Patients" Cancers 16, no. 4: 683.
https://doi.org/10.3390/cancers16040683
APA Style
Poole, R. A., Wang, Q., Ray, A., Takabe, K., Opyrchal, M., & Katsuta, E.
(2024). Increased PIEZO1 Expression Is Associated with Worse Clinical Outcomes in Hormone-Receptor-Negative Breast Cancer Patients. Cancers, 16(4), 683.
https://doi.org/10.3390/cancers16040683